News - Page 13 - Psychedelic Alpha

Read more about the article Pα+ Psychedelic Bulletin #164: Lykos Dominates News Cycle; EPIsoDE Trial Readout; EU Drug Report Discusses Psychedelics; DEA Should Improve RFRA Petition Process; Other News

Pα+ Psychedelic Bulletin #164: Lykos Dominates News Cycle; EPIsoDE Trial Readout; EU Drug Report Discusses Psychedelics; DEA Should Improve RFRA Petition Process; Other News

Post published:June 14, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Breaking: Lykos Therapeutics Moved to Patent MDMA In Late 2022, Filing Reveals

Breaking: Lykos Therapeutics Moved to Patent MDMA In Late 2022, Filing Reveals

Post published:June 13, 2024
Post category:Analysis News

Read more about the article Natural Medicine Advisory Bulletin 11.5: Rule Review & Roadmap

Natural Medicine Advisory Bulletin 11.5: Rule Review & Roadmap

Post published:June 11, 2024
Post category:Colorado Natural Medicine Advisory Bulletin

Read more about the article Analysis: FDA Advisory Committee Snubs MDMA-Assisted Therapy for PTSD in Overwhelming “No” Vote

Analysis: FDA Advisory Committee Snubs MDMA-Assisted Therapy for PTSD in Overwhelming “No” Vote

Post published:June 11, 2024
Post category:Analysis News Pα+

Read more about the article Live Coverage: FDA Advisory Committee Reviews MDMA-Assisted Therapy for PTSD

Live Coverage: FDA Advisory Committee Reviews MDMA-Assisted Therapy for PTSD

Post published:June 4, 2024
Post category:Analysis News

Read more about the article ICER Panel Rejects MDMA-Assisted Therapy, Highlights Evidence Gaps and Study Flaws in 14-1 Vote

ICER Panel Rejects MDMA-Assisted Therapy, Highlights Evidence Gaps and Study Flaws in 14-1 Vote

Post published:May 31, 2024
Post category:Analysis News Pα+

Read more about the article Patients, Practitioners, Researchers and Public Submit Comments Ahead of FDA Advisory Committee on MDMA

Patients, Practitioners, Researchers and Public Submit Comments Ahead of FDA Advisory Committee on MDMA

Post published:May 29, 2024
Post category:Analysis Pα+

Read more about the article What to Expect: FDA Advisory Committee Set to Review MDMA-Assisted Therapy for PTSD

What to Expect: FDA Advisory Committee Set to Review MDMA-Assisted Therapy for PTSD

Post published:May 27, 2024
Post category:Analysis Pα+

Read more about the article Pα+ Psychedelic Patent Analysis: April 2024

Pα+ Psychedelic Patent Analysis: April 2024

Post published:May 24, 2024
Post category:Psychedelic Patent Analysis Pα+

Read more about the article Pα+ Psychedelic Bulletin #163: Tempering Excitement Around Recent Raises; Compass Shares Cut of Open-Label PTSD Data; Other News

Pα+ Psychedelic Bulletin #163: Tempering Excitement Around Recent Raises; Compass Shares Cut of Open-Label PTSD Data; Other News

Post published:May 17, 2024
Post category:Psychedelic Bulletin Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.